Sort
39,280 grants matching “leukemia”
Decoding innate immune signaling in normal and myelodysplastic hematopoiesis
$788,750Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R35 · FY2020 · HL
Decoding innate immune signaling in normal and myelodysplastic hematopoiesis
$788,750Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R35 · FY2017 · HL
Regulation of SIGNALLING PATHWAYS INVOLVING NUCLEAR FACTOR KAPPA B
$788,279Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Identification of human tumor-associated antigens
$788,196Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
FUNCTION OF LACTOSAMINYL GLYCANS IN EARLY HEMATOPOIETIC AND MYELOPOIETIC CELLS
$788,188Robert Sackstein · Brigham And Women'S Hospital · P01 · FY2012 · HL
CD4 Redirected Chimeric Antigen Receptor T Cell Therapy for CD4 Positive T Cell Neoplasms
$788,134Huda Salman · Indiana University Indianapolis · R01 · FY2024 · FD
A Training Program in Molecular Hematology
$787,920Robert I Handin · Harvard Medical School · T32 · FY2006 · HL
FUNCTION OF LACTOSAMINYL GLYCANS IN EARLY HEMATOPOIETIC AND MYELOPOIETIC CELLS
$787,917Robert Sackstein · Brigham And Women'S Hospital · P01 · FY2016 · HL
CORE C Technology Implementation/Development and Correlative Sciences
$787,787Friederike Herbst-Nowrouzi · University Of Pennsylvania · P01 · FY2024 · CA
Improving Informed Consent in Childhood Cancer Trials
$787,629Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2005 · CA
Low-Cost Digital Gene Expression System
$787,516Steven Jeffrey Gordon · Intelligent Bio-Systems, Inc. · R44 · FY2012 · CA
CD4 Redirected Chimeric Antigen Receptor T Cell Therapy for CD4 Positive T Cell Neoplasms
$787,515Huda Salman · Indiana University Indianapolis · R01 · FY2023 · FD
Occupational Exposure Assessment
$787,363Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Transformative Computational Infrastructures for Cell-Based Biomarker Diagnostics
$787,091Yu Qian · J. Craig Venter Institute, Inc. · U01 · FY2018 · TR
Occupational Exposure Assessment
$786,835Melissa Friesen · Division Of Cancer Epidemiology And Genetics · ZIA · FY2019 · CA
CALGB STUDIES OF BREAST CANCER IN THE ELDERLY
$786,715University Of Chicago · U10 · FY2004 · CA
Next Generation Therapies for Fertility Preservation in Male Cancer Patients
$786,272Kyle E Orwig · Magee-Women'S Res Inst And Foundation · R01 · FY2024 · HD
Studies in the Pathogenesis of Systemic Capillary Leak Syndrome
$786,038Kirk Druey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
$785,520Ehab L Atallah · Medical College Of Wisconsin · R01 · FY2014 · CA
FANCONI ANEMIA:GENOTYPE-PHENOTYPE CORRELATIONS
$785,364Settara Chandrasekharappa · National Human Genome Research Institute · ZIA · FY2017 · HG
Retrovirus Biology
$785,353Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Digital PCR quantification of BCR-ABL for CML diagnosis and monitoring in a LMICs setting
$784,911Daniel T Chiu · University Of Washington · UH3 · FY2019 · CA
MONITORING OF RESIDUAL DISEASE IN PEDIATRIC ALL
$784,835University Of New Mexico · R01 · FY2001 · CA
Developing novel therapies to improve blood stem cell transplantation outcomes
$783,992Ramiro Garzon · Ohio State University · R01 · FY2022 · HL
Molecular pathogenesis and therapy innovation for Merkel cell carcinoma
$783,873Isaac Brownell · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA